Resistance, Remission, and Qualitative Differences in HIV Chemotherapy
To understand the role of qualitative differences in multidrug chemotherapy for human immunodeficiency virus (HIV) infection in virus remission and drug resistance, we designed a mathematical system that models HIV multidrug chemotherapy including uninfected CD4+ T cells, infected CD4+ T cells, and...
Main Authors: | Denise E. Kirschner, G.F. Webb |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
1997-09-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/3/3/97-0303_article |
Similar Items
-
Proteases of Malaria Parasites: New Targets for Chemotherapy
by: Philip J. Rosenthal
Published: (1998-03-01) -
HIV-1 Patients May Harbor Viruses of Different Phylogenetic Subtypes: Implications for the Evolution of the HIV/AIDS Pandemic
by: Danuta Pieniazek, et al.
Published: (1995-07-01) -
Recombination in HIV: An Important Viral Evolutionary Strategy
by: Donald S. Burke
Published: (1997-09-01) -
Host Genes and HIV Infection: Implications and Applications
by: Richard A. Kaslow
Published: (1997-09-01) -
HIV Infection as a Risk Factor for Shigellosis
by: Jefferson T. Baer, et al.
Published: (1999-12-01)